RUNX1 and glioblastoma: In glioblastoma (GBM), knocking down RUNX1 in U-87 MG cells inhibited angiogenesis, with p38 MAPK pathway inhibition by SB203580 denoting RUNX1's involvement in promoting vascular growth via the p38 MAPK signaling pathway 54.